Related Experiment Video
Updated: May 5, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Antiviral Activity of Brazilian Propolis from Stingless Bees Against Rotavirus
Guadalupe González-Ochoa1, Ana Paola Balderrama-Carmona1, Jesús Antonio Erro-Carvajal1
1Laboratorio de Microbiología e Inmunología, Departamento de Ciencias Químico-Biológicas y Agropecuarias, Facultad Interdisciplinaria de Ciencias Biológicas y de la Salud, Universidad de Sonora, Navojoa 85880, Mexico.
Insights
Stingless bee propolis effectively reduced Group A rotavirus (RV) infectivity by over 99%. This natural compound shows promise as a safe antiviral agent for gastrointestinal infections.
Area of Science:
- Virology
- Immunology
- Natural Products Chemistry
Background:
- Group A rotavirus (RV) is a major cause of infant gastroenteritis globally.
- No specific antiviral treatment currently exists for rotavirus infections.
- Propolis, a natural resin, possesses known antimicrobial and antiviral properties.
Purpose of the Study:
- To investigate the antiviral activity of stingless bee propolis against Group A rotavirus.
- To determine the safety and efficacy of propolis extracts in combating RV infection.
Main Methods:
- Cytotoxicity was assessed using the MTT assay on colon adenocarcinoma cells.
- Viral infectivity reduction was quantified via focus-forming assays.
- Propolis extracts from specific stingless bee species were tested.
Main Results:
- Stingless bee propolis demonstrated no cytotoxicity at concentrations up to 200 µg/mL.
- Propolis from *Plebeia droryana* and *Melipona quadrifasciata* reduced RV infectivity by over 99%.
- Brazilian stingless bee propolis exhibited significant antiviral effects against RV.
Conclusions:
- Brazilian stingless bee propolis possesses potent antiviral activity against Group A rotavirus.
- Propolis is a promising candidate for developing novel antiviral therapies for rotavirus infections.
- Further research supports propolis's potential application as a natural antiviral agent.
Abstract:
Group A rotavirus (RV) causes gastrointestinal disease in infants worldwide, and there is currently no specific treatment to eliminate the virus. Due to its chemical properties, propolis is a promising compound for improving gastrointestinal infections. This study aimed to evaluate the action of stingless bee propolis against RV. The method involved determining the concentrations of the extracts that do not exhibit cytotoxicity in colon adenocarcinoma cells using the MTT assay and measuring the reduction in infectivity through a focus forming assay. The results showed that stingless bee propolis was non-cytotoxic up to 200 µg/mL. The reduction in RV infectivity exceeded 99% when using propolis from Plebeia droryana and Melipona quadrifasciata. Brazilian stingless bee propolis, whose active components are known for their activity against various viruses, was experimentally tested and demonstrated effective antiviral activity against RV, supporting its potential application as an antiviral agent.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis

